Resultsbee.com

200 Medical Plaza Driveway Suite 265,Los Angeles,CA

Grace M. Aldrovandi, MD CM, is a physician-scientist and Chief of the Division of Infectious Diseases at UCLA Mattel Children’s Hospital and a Professor of Pediatrics at the David Geffen School of Medicine of the University of California, Los Angeles. Dr. Aldrovandi is a board-certified pediatric infectious diseases specialist with over 20 years experience in caring for both general pediatric infectious diseases as well as HIV infected children and their families. Dr. Aldrovandi’s research interests include pediatric HIV, the effects of breast milk on child health and infections in immunocompromised children. She has published more than 100 peer review publications in such journals as Nature, Journal of Virology, and the New England Journal of Medicine and multiple book chapters. She has been a member of multiple National Institutes of Health study sections and lectured throughout the world. She also was invited by the National Institutes of Health (NIH) to serve as a member of the AIDS Immunology and Pathogenesis Study Section of the Center for Scientific Review. As a researcher, Dr. Aldrovandi has chaired national and international studies on HIV pathogenesis within the International Maternal, Pediatric and Adolescent AIDS Clinical Trials Network (IMPAACT) and the Adolescent Trials Network (ATN). She was elected Chair of the IMPAACT Laboratory Committee, where she provides scientific leadership and quality assurance/quality control programs for all the laboratories (Virology, Immunology, Pharmacology and Genetics). Dr. Aldrovandi was recently selected to Chair the AIDS Clinical Trials Group (ACTG) Laboratory Center in addition where she performs similar duties. She is the former Chair of the Pediatric AIDS Clinical Trials Group (PACTG) Virology Committee and a member of the phenotypic and genotypic resistance working groups as well as the dried blood spot swat team. She is also a member of the Genotypic Advisory Committee of the NIAID VQA to establish a DAIDS quality assurance program for genotypic analysis of drug resistance mutations. She has considerable scientific expertise in pediatric HIV, basic HIV virology, HIV clinical assays and HIV drug resistance. Dr. Aldrovandi has been awarded the prestigious Elizabeth Glaser Scientist Award for her work on breast milk transmission of HIV-1. More recently, Dr. Aldrovandi has investigated the role of the microbiome in normal infant development, how the microbiome is perturbed by HIV-1, and how the microbiome affects HIV-1 susceptibility at mucosal sites. Her initial interest in the microbiome developed from her studies of breast milk and breast milk transmission of HIV-1. Mother’s actively excrete bacteria and special proteins, human milk oligosaccharides, thought to support the commensal bacterial, to their infants via breast milk. Certain immune cells in the infant gut do not develop until the cells receive signals from the commensal bacteria. It is this complex interplay between mother, infant and microbe that Dr. Aldrovandi is trying to understand through many of her microbiome studies. Additionally, her investigations have expanded to improve the understanding of the microbiome in HIV susceptibility and its role in human disease and treatment response. Dr. Aldrovandi received two bachelor’s degrees and her medical degree from McGill University in Montreal, Canada. She completed an internship and residency at McGill, as well as a research fellowship in pediatric infectious diseases at the University of California, Los Angeles.

(131) 082 - 5086

200 Medical Plaza Driveway Suite 22-442 MDCC,Los Angeles,CA

James D. Cherry, MD, MSc is a Distinguished Research Professor at the David Geffen School of Medicine at UCLA and UCLA Mattel Children's Hospital, Division of Infectious Diseases. Dr. Chery received his MD degree from the University of Vermont in 1957 and his MSc degree in Epidemiology from the London School of Hygiene and Tropical Medicine in 1983. He received his pediatric residency training at Boston City Hospital and Kings County Hospital and his infectious diseases fellowship training at the Thorndike Memorial Laboratory, Harvard Medical Service at Boston City Hospital. Following his infectious diseases fellowship training, Dr. Cherry established one of the first formal pediatric infectious disease fellowship programs in the world in 1963 at the University of Wisconsin. In 1973 Dr. Cherry started the first pediatric infectious training program at UCLA. During his 47 years tenure at UCLA, numerous trainees have gone on to be leaders in pediatric infectious diseases in the United States and other countries throughout the world. In 1969-70, Dr. Cherry was a visiting worker at the Medical Research Council, Common Cold Research Unit and Clinical Research Centre, Salisbury, England. From 1989 to 1996, Dr. Cherry and associates carried out an extensive pertussis vaccine efficiency trail in Erlanger, Germany. In 2000-2001, he was a visiting scholar in the Department of Clinical Veterinary Medicine, University of Cambridge, England. In addition, Dr. Cherry was the director of a vaccine reaction study in Denmark at a participant in two USAID nutrition/immunology projects in Kenya. Throughout his career, Dr. Cherry has received numerous national and international awards. Some of these include: The John and Mary B. Markle Scholar in Academic Medicine; Distinguished Physician Award of the Pediatric Infectious Diseases Society; The Stanley A. Plotkin Lectureship in Vaccinology of the Pediatric Infectious Diseases Society; The European Society for Pediatric Infectious Diseases Bill Marshall Award; The American Academy of Pediatrics Section on Infectious Diseases Award for Lifetime Contribution to Infectious Diseases Education; and The UCLA, Edward A. Dickson Emeritus Professorship Award. Dr. Cherry has published 323 research papers, 109 editorials and commentaries and 303 book chapters. He is the senior editor of Feigin and Cherry's Textbook of Pediatric Infectious Disease, which is now in its 8th edition. Dr. Cherry's laboratory experience involved virology, mycoplasmology, serology, and molecular microbiology. His main research over the last 57 years has been related to vaccines and vaccine preventable diseases (measles, rubella, influenza, smallpox, and pertussis). A major interest since 1976 relates to pertussis epidemiology and pertussis vaccines. Over the last 10 years, he and colleagues at the California Department of Public Health and California pediatric infectious diseases physicians have been studying severe pertussis in young infants. Another area of interest has been measles and measles vaccines. He and colleagues first described secondary measles vaccine failure in 1972 in Saint Louis and more recently in California. He presently is involved in measles related studies in the Democratic Republic of the Congo and in Switzerland. Finally, he has been involved in Zika virus studies in Brazil.

(131) 082 - 5522

23440 Hawthorne Boulevard Suite 115,Torrance,CA

Dr. Shen Ling came to the U.S in his early life, and has been through rigorous and highly competitive training throughout his career. With a biology major, he continued onto graduate studies at UCLA, and then entered prestigious Harvard School of Dental Medicine where he graduated with Magna Cum Laude honors in 1994. He furthered his education, returning to UCLA, with an three-year specialty residency training program in periodontics and implant surgery. In 2001 Dr. Ling became Fellow of the International Congress of Oral Implantologists (ICOI). Dr. Ling is a consultant to several dental manufacturers, and frequently speaks at national meetings and study groups. His most recent lecture was given at an international implant meeting in Shanghai, China. While at Harvard and at UCLA, Dr. Ling was involved with research in anti-microbial therapy in periodontics and non-surgical therapy which have won him awards and resulted in scientific publications in several dental journals. Dr. Ling limits his clinical practice to surgical and conservative periodontics, periodontal plastic surgery, soft and hard tissue reconstructive surgery, and surgical aspects of dental implants. He is currently a part-time lecturer at UCLA School of Dentistry. Dr. Ling spends most of his personal time his personal time mostly with his two daughters, and is a soccer coach for their teams. He is married to Dr. Wei Huang, MD.

(132) 330 - 6254

637 Lucas Avenue Suite 101,Los Angeles,CA

Dr. C. Suzanne Cutter delivers premium surgical oncology care using compassion and candor with an emphasis on empowering patients. As the founder of CUREtology Surgical Oncology and Associates, Dr. Cutter leaves no stone unturned when it comes to diagnosing and treating her patients in the Downtown Los Angeles area, giving them the tools they need to fight back against a cancer diagnosis. As part of her comprehensive care, Dr. Cutter espouses a holistic approach that helps her patients from every angle. To that end, shes instituted a program called HONERR© (hydration, organ detoxification, nutrition, exercise, rest, and relationships), which empowers her patients to care for themselves on every level for better overall health and wellness. Dr. Cutter travels domestically and internationally to teach and provide care for cancer patients around the world. Her clinical and research training allow her to address tumors throughout the body except for the brain, bone, and heart, and her special interests include sarcomas, melanoma, and thyroid disease. After a career in technology, which focused on health care, Dr. Cutter took a self-directed sabbatical to study medicine in Chicago. Her surgical training consisted of a general surgery residency in New York, a cancer research fellowship also in New York and a surgical oncology clinical fellowship in Los Angeles. Dr. Cutters education and training exposed her to a wide variety of patients, pathologies, and practice patterns through experiences at major institutions, both domestic and abroad. She performs global medical missions once or twice per year in order to deliver education to the far reaches of the globe. Dr. Cutter holds licenses in multiple states, which allows her to deliver care via telemedicine for initial consultations and postoperative wound checks for patients outside of Los Angeles in Arizona, Colorado, New York, and Minnesota.

(121) 326 - 1710

757 Westwood Plaza,Los Angeles,CA

Dr. Sherin U. Devaskar is Executive Chair of the Department of Pediatrics at UCLA. Hospital Appointments Physician-in-Chief, Mattel Children's Hospital Sherin U. Devaskar, MD is Distinguished Professor of Pediatrics, Mattel Executive Endowed Chair of the Department of Pediatrics at the David Geffen School of Medicine at UCLA. She is the Physician-in-Chief, Mattel Children's Hospital UCLA, and Assistant Vice Chancellor of Children’s Health, UCLA Health. She is also the Executive Director of the UCLA Children's Discovery and Innovation Institute (CDI). Dr. Devaskar is a highly accomplished pediatrician/neonatologist, researcher and educator. She was selected as the recipient of the 2021 John Howland Award and Medal for Highest Achievements in promoting child health as a leader, physician-scientist, mentor and clinician-educator. Dr. Devaskar's research is renowned for elucidating mechanisms and processes responsible for developmental origins of chronic childhood disorders such as obesity and diabetes with a recent emphasis on the effect of placental health on neurodevelopment. Her research is supported by National Institutes of Health (NIH). Dr. Devaskar has authored over 160 publications in peer-reviewed journals. She served as a member of the National Advisory Child Health and Human Development Council, National Institutes of Health, Chair of the NICHD-Maternal and Child Health Committee and Chair of the NIH-Human and Embryology Study Section. She was also the President of the American Pediatric Society and served on the International Pediatric Research Foundation Board. She is currently the President of the American Medical School Pediatric Department Chairs. Dr. Devaskar was elected to the Institute of Medicine (IOM) in October 2012. Dr. Devaskar has a particular interest in academic development and focuses on supporting and mentoring fellows and junior faculty interested in becoming physician-scientists, clinician-researchers or educators. Dr. Devaskar serves on multiple UCLA, national and international committees. She served as the Chair of the Scientific Program Committee for the Pediatric Academic Societies. She was a member of the Perinatal-Neonatal Subsection of the American Board of Pediatrics. Dr. Devaskar served as the Editor-in-Chief of the Pediatric Research journal. More locally, she is known to Pediatricians and Families in the Los Angeles Area, given her. passion for providing the best and safe care in a family centered manner for babies and children and has worked tirelessly to make this happen

(131) 082 - 5943

2020 Santa Monica Blvd. Suite 540,Santa Monica,CA

Dr. Tanaz Kermani is the Founder and Director of the multi-disciplinary Vasculitis Program at UCLA. She grew up in Mumbai and moved to the United States in 1996 to pursue higher education. She completed her training in Internal Medicine, Rheumatology at the Mayo Clinic in Minnesota. She joined the UCLA Health's Division of Rheumatology in 2012. She sees patients with all rheumatological diagnoses and has a special interest and expertise in vasculitis. She completed additional training in vasculitis at the Mayo Clinic, as part of a prestigious Vasculitis Clinical Research Consortium fellowship. She is an active member of the vasculitis research community, with multiple ongoing national and international collaborations with vasculitis patient advocates and medical experts. She has published several vasculitis research studies. Dr. Kermani is deeply concerned and invested in the well-being of her patients. Her approach is to listen to her patients, and provide them with the best treatment options so she and the patients can make joint decisions concerning the best way to proceed.

(131) 058 - 2635